Vigabatrin vs placebo
50% or greater reduction in seizure frequency · people (aged 10–64 years) with drug‐resistant focal epilepsy
Vigabatrin may leads to higher ≥ 50% reduction in seizure frequency (ITT analysis) Duration of… compared with placebo (low certainty).
1 finding from 1 review
- RR 2.6 [1.87, 3.63]4 studies · 513 participantsLow